Cultural Misalignment and Lack of Strategic Focus - Anonymous employee GoodRx Employee Review

1.0
May 9, 2025
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

• Talented individuals in certain teams who care deeply about the mission • Flexible work policies in some departments • Exposure to cross-functional teams and enterprise-level challenges

Cons

While the company has made some visible efforts to improve performance, broader structural and cultural challenges continue to hinder progress. Leadership tends to prioritize perception and internal alignment over substantive delivery and technical excellence. As a result, meaningful impact is often sidelined in favor of image-driven initiatives. The organizational environment can feel politically charged, with limited space for collaborative problem-solving. High-performing individuals may find it difficult to thrive in a system that rewards optics over execution and where constructive feedback is often misinterpreted as dissent. Moreover, there appears to be a lack of long-term product vision and investment in talent development. Technical leadership is undervalued, and managers are often better known for controlling narrative than for enabling teams. This culture has contributed to high attrition among strong contributors and reinforces a cycle where blame and role ambiguity persist.

Explore other reviews about GoodRx

5.0
May 14, 2026
Recommend
CEO approval
Business Outlook

Pros

Great space to learn, encouraged learning from mistakes, great overall positive attitude and collaboration amongst eng and non-eng co-workers

Cons

Started to feel more of a company that started prioritizing profits and started to think of several products to ship out without much support for the reason or long term support to improve the products.

1
4.0
Jun 23, 2026
Recommend
CEO approval
Business Outlook

Pros

Great compensation and benefits. Extreme work flexibility. Mission driven work where you know your directly helping Americans access important health care. Company is taking a great measured approach to AI adoption.

Cons

GoodRx is an established dominant player in the prescription drug space and is starting to flounder a bit in the face of stiff, more digital first, competition. Unclear what the future holds and this is reflected in the stock price. As such project direction can be a bit vague. Similarly a long history of tech debt, further muddled by HIPAA requirements, can make product development painful.

See reviews by: Helpful|Rating|Date|All